William Blair initiated coverage on Kailera Therapeutics
Stocks in this Quantisnow insightHealth Care
Historical context for KLRA
Across the 3 sessions after earlier KLRA headlines, the stock closed higher 1 times and lower 2 times, with a median move of 2.7% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | KLRA | SPY |
|---|---|---|---|
| May 12, 2026 | Analyst initiated coverage on Kailera Therapeutics with a new price targetand 4 other headlines that session | -2.7% | -0.2% |
| Apr 22, 2026 | Hengrui Pharma Reports Q1 2026 Results with Revenue and Net Profit Growth | -3.6% | +1.0% |
| Apr 21, 2026 | Kailera Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares | +2.5% | -0.7% |
Keep researching KLRA
- What is Initiation of coverage?The first research report an analyst or brokerage publishes on a company, setting an opening rating and price target.
- Analyst upgrades and downgradesAn analyst upgrade or downgrade is a change in a sell-side analyst's stock rating. Learn what Buy, Hold and Sell mean, how price targets work and which changes matter.
- KLRA insider tradesEvery buy and sale reported by Kailera Therapeutics Inc. officers, directors and large holders.
- KLRA earnings historyPast Kailera Therapeutics Inc. earnings releases, newest first.
Quantisnow market dataNASDAQ
KLRA
Kailera Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2026
Get push alerts for KLRA
Full KLRA profile on Quantisnow Follow KLRA and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time